Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples